COVID-19 has created new impetus for the battle against Diabesity.  The need to resolve the interlinked epidemics of diabetes and obesity, which the WHO calls the 21st Century Plague, is more dire than ever.  COVID-19 is opportunistically exploiting an underlying susceptibility of those living with these chronic health conditions.  According to the CDC, and as reported in a study published in the Journal of the American Medical Association (April 22, 2020), comorbidity resulting from hypertension (56.6%), obesity (41.7%) and diabetes (33.8%) increase the risk of infection and serious outcomes from COVID-19 including invasive medical ventilation, kidney replacement and death.The post COVID-19 world will result in shifting priorities and new adaptations.  COVID-19 has increased the stakes at all levels, requiring a consolidated effort by individuals, health professionals and politicians to tackle Diabesity at its source.  While we currently lack the tools to combat COVID-19, we do have the knowledge and opportunity to win